2a8h: Difference between revisions
New page: left|200px<br /> <applet load="2a8h" size="450" color="white" frame="true" align="right" spinBox="true" caption="2a8h, resolution 2.30Å" /> '''Crystal structure o... |
No edit summary |
||
Line 1: | Line 1: | ||
[[Image:2a8h.gif|left|200px]]<br /> | [[Image:2a8h.gif|left|200px]]<br /><applet load="2a8h" size="350" color="white" frame="true" align="right" spinBox="true" | ||
<applet load="2a8h" size=" | |||
caption="2a8h, resolution 2.30Å" /> | caption="2a8h, resolution 2.30Å" /> | ||
'''Crystal structure of catalytic domain of TACE with Thiomorpholine Sulfonamide Hydroxamate inhibitor'''<br /> | '''Crystal structure of catalytic domain of TACE with Thiomorpholine Sulfonamide Hydroxamate inhibitor'''<br /> | ||
==Overview== | ==Overview== | ||
A series of thiomorpholine sulfonamide hydroxamate TACE inhibitors, all | A series of thiomorpholine sulfonamide hydroxamate TACE inhibitors, all bearing propargylic ether P1' groups, was explored. In particular, compound 5h has excellent in vitro potency against isolated TACE enzyme and in cells, oral activity in a model of TNF-alpha production and a collagen-induced arthritis model, was selected as a clinical candidate for the treatment of RA. | ||
==About this Structure== | ==About this Structure== | ||
2A8H is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with ZN and 4NH as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/ADAM_17_endopeptidase ADAM 17 endopeptidase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.24.86 3.4.24.86] Full crystallographic information is available from [http:// | 2A8H is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with <scene name='pdbligand=ZN:'>ZN</scene> and <scene name='pdbligand=4NH:'>4NH</scene> as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/ADAM_17_endopeptidase ADAM 17 endopeptidase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.24.86 3.4.24.86] Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2A8H OCA]. | ||
==Reference== | ==Reference== | ||
Line 16: | Line 15: | ||
[[Category: Single protein]] | [[Category: Single protein]] | ||
[[Category: Barone, D.]] | [[Category: Barone, D.]] | ||
[[Category: Chen, J | [[Category: Chen, J M.]] | ||
[[Category: Cummons, T.]] | [[Category: Cummons, T.]] | ||
[[Category: Du, M.]] | [[Category: Du, M.]] | ||
[[Category: Jin, G.]] | [[Category: Jin, G.]] | ||
[[Category: Laakso, L | [[Category: Laakso, L M.]] | ||
[[Category: Levin, J | [[Category: Levin, J I.]] | ||
[[Category: Schmid, J.]] | [[Category: Schmid, J.]] | ||
[[Category: Skotnicki, J | [[Category: Skotnicki, J S.]] | ||
[[Category: Xu, J.]] | [[Category: Xu, J.]] | ||
[[Category: Xu, W.]] | [[Category: Xu, W.]] | ||
Line 32: | Line 31: | ||
[[Category: zn-endopeptidase]] | [[Category: zn-endopeptidase]] | ||
''Page seeded by [http:// | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 16:24:49 2008'' |
Revision as of 17:25, 21 February 2008
|
Crystal structure of catalytic domain of TACE with Thiomorpholine Sulfonamide Hydroxamate inhibitor
OverviewOverview
A series of thiomorpholine sulfonamide hydroxamate TACE inhibitors, all bearing propargylic ether P1' groups, was explored. In particular, compound 5h has excellent in vitro potency against isolated TACE enzyme and in cells, oral activity in a model of TNF-alpha production and a collagen-induced arthritis model, was selected as a clinical candidate for the treatment of RA.
About this StructureAbout this Structure
2A8H is a Single protein structure of sequence from Homo sapiens with and as ligands. Active as ADAM 17 endopeptidase, with EC number 3.4.24.86 Full crystallographic information is available from OCA.
ReferenceReference
Acetylenic TACE inhibitors. Part 3: Thiomorpholine sulfonamide hydroxamates., Levin JI, Chen JM, Laakso LM, Du M, Schmid J, Xu W, Cummons T, Xu J, Jin G, Barone D, Skotnicki JS, Bioorg Med Chem Lett. 2006 Mar 15;16(6):1605-9. Epub 2006 Jan 19. PMID:16426848
Page seeded by OCA on Thu Feb 21 16:24:49 2008